GLP-1 medications have generally been well-tolerated for long-term use, though they may have mild to moderate side effects such as nausea, vomiting, diarrhea, abdominal discomfort, or occasional constipation
Efstratiadis A Roles of Growth Hormone and Insulin-like Growth Factor 1 in Mouse Postnatal Growth
Copper Peptide Research Guide 2026 GHK-Cu research guide copper peptide mechanisms, research applications, and UK sourcing information
23, 379385 10.1248/bpb.23.379 [DOI] [PubMed] [Google Scholar] Kim S., Park S
However, a better understanding of the intricate relationship between cancer risk and thiol status may unravel new initiatives that could incorporate folate supplementation as a means of chemoprevention in high risk individuals
In a trial of patients with T2DM and a BMI of 27 kg/m2 or greater being treated with semaglutide injection for weight loss, clinically significant hypoglycemia (plasma glucose less than 54 mg/dL) was reported in 6.2% of semaglutide-treated patients versus 2.5% of placebo-treated patients
